Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX® STATdose(TM) system

Clinical Therapeutics

Volumn 18, Issue 4, 1996, Pages 687-699

  Mushet, George R ^a   Cady, Roger K ^b   Baker, C Camak ^c   Clements, Bill ^d   Gutterman, Donna L ^d   Davis, Randy ^d  

^a Georgia Headache Treatment Center   (United States)

^b HEADACHE CARE CENTER   (United States)

^c Headache Institute of Minnesota   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; AMITRIPTYLINE; ASCRIPTIN; ATENOLOL; CYPROHEPTADINE; DILTIAZEM; FLUOXETINE; IMIPRAMINE; KETOPROFEN; LITHIUM CARBONATE; METHYSERGIDE; METOPROLOL; NADOLOL; NIFEDIPINE; NORTRIPTYLINE; PERPHENAZINE; PHENELZINE; PLACEBO; PROPRANOLOL; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TRAZODONE; VALPROIC ACID; VERAPAMIL;

ADULT; ARTHRALGIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INJECTION PAIN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; MUSCLE CRAMP; NAUSEA; PHARMACEUTICS; PHOTOPHOBIA; RANDOMIZED CONTROLLED TRIAL; SKIN TINGLING; SUBCUTANEOUS DRUG ADMINISTRATION; THORAX PAIN; VOMITING;

EID: 0029785752     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80219-0     Document Type: Article

References (11)

1. Rose FC. Sumatriptan: An overview. Headache Q. 1993;4(Suppl 2):37-41.
2. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. NEJM. 1991; 325:316-321.
3. Cady RK, Wendt JK, Kirchner JF, et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991;265: 2831-2835.
4. The Oral Sumatriptan Dose-Defining Study Group. Sumatriptan - an oral dose-defining study. Eur Neurol. 1991;31: 300-305.
5. The Oral Sumatriptan International Multiple-Dose Study Group. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol. 1991;31:306-313.
6. Schoenen J, Bulcke J, Caekebeke J, et al. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: Comparison with customary treatment in a open, longitudinal study. Cephalalgia. 1994;14:55-63.
7. The Sumatriptan Auto-Injector Study Group. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. Eur Neurol. 1991; 31:323-331.
8. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8:1-96.
9. Gross MLP, Kay J, Turner AM, et al. Sumatriptan in acute migraine using a novel cartridge system self-injector. Headache. 1994;34:559-563.
10. Ottervanger JP, Stricker JC. Cardiovascular adverse reactions to sumatriptan. Cns Drugs. 1995;3:90-98.
11. Imitrex® (sumatriptan succinate) Injection Product Information. Cerenex Pharmaceuticals, Division of Glaxo Wellcome Ine, Research Triangle Park, NC, May 1994.